Aimmune Therapeutics, Inc. Current Ratio 2015-2020 | AIMT
Aimmune Therapeutics, Inc. current ratio from 2015 to 2020. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
| Current Ratio Historical Data | |||
|---|---|---|---|
| Date | Current Assets | Current Liabilities | Current Ratio |
| 2020-06-30 | $0.32B | $0.04B | 7.53 |
| 2020-03-31 | $0.37B | $0.05B | 8.10 |
| 2019-12-31 | $0.15B | $0.05B | 3.14 |
| 2019-09-30 | $0.20B | $0.04B | 4.64 |
| 2019-06-30 | $0.25B | $0.04B | 5.80 |
| 2019-03-31 | $0.29B | $0.04B | 7.65 |
| 2018-12-31 | $0.31B | $0.04B | 8.22 |
| 2018-09-30 | $0.26B | $0.04B | 6.99 |
| 2018-06-30 | $0.30B | $0.04B | 8.22 |
| 2018-03-31 | $0.33B | $0.03B | 10.86 |
| 2017-12-31 | $0.19B | $0.03B | 7.11 |
| 2017-09-30 | $0.22B | $0.02B | 10.29 |
| 2017-06-30 | $0.24B | $0.02B | 13.45 |
| 2017-03-31 | $0.25B | $0.01B | 24.34 |
| 2016-12-31 | $0.25B | $0.01B | 21.98 |
| 2016-09-30 | $0.15B | $0.01B | 12.88 |
| 2016-06-30 | $0.17B | $0.01B | 29.56 |
| 2016-03-31 | $0.19B | $0.01B | 34.82 |
| 2015-12-31 | $0.20B | $0.01B | 38.73 |
| 2015-09-30 | $0.22B | $0.00B | 70.25 |
| 2015-06-30 | $0.06B | $0.00B | 18.22 |
| 2015-03-31 | $0.00B | 0.00 | |
| 2014-09-30 | $0.00B | 0.00 | |
| 2014-06-30 | $0.00B | 0.00 | |
